Odyssean LLC Increases Stock Position in Colgate-Palmolive Company $CL

Odyssean LLC raised its position in shares of Colgate-Palmolive Company (NYSE:CL) by 236.0% in the second quarter, Holdings Channel.com reports. The fund owned 13,316 shares of the company’s stock after buying an additional 9,353 shares during the quarter. Odyssean LLC’s holdings in Colgate-Palmolive were worth $1,221,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Kemnay Advisory Services Inc. acquired a new stake in Colgate-Palmolive in the 4th quarter valued at $25,000. CBIZ Investment Advisory Services LLC lifted its stake in shares of Colgate-Palmolive by 86.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock worth $26,000 after purchasing an additional 150 shares in the last quarter. TD Capital Management LLC boosted its position in shares of Colgate-Palmolive by 61.4% in the fourth quarter. TD Capital Management LLC now owns 326 shares of the company’s stock worth $26,000 after buying an additional 124 shares during the period. Triumph Capital Management boosted its position in shares of Colgate-Palmolive by 62.9% in the fourth quarter. Triumph Capital Management now owns 329 shares of the company’s stock worth $26,000 after buying an additional 127 shares during the period. Finally, Jessup Wealth Management Inc acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $26,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insiders Place Their Bets

In other news, Director John Cahill sold 4,170 shares of the firm’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $93.37, for a total value of $389,352.90. Following the transaction, the director directly owned 28,373 shares in the company, valued at approximately $2,649,187.01. This trade represents a 12.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Panagiotis Tsourapas sold 10,000 shares of Colgate-Palmolive stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $92.05, for a total transaction of $920,500.00. Following the completion of the transaction, the chief operating officer directly owned 64,901 shares of the company’s stock, valued at $5,974,137.05. This trade represents a 13.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 175,191 shares of company stock valued at $16,110,903 over the last 90 days. 0.43% of the stock is owned by company insiders.

Analyst Ratings Changes

CL has been the topic of several recent research reports. Sanford C. Bernstein reissued a “market perform” rating on shares of Colgate-Palmolive in a research report on Thursday, August 13th. JPMorgan Chase & Co. dropped their price objective on shares of Colgate-Palmolive from $104.00 to $103.00 and set an “overweight” rating on the stock in a research note on Monday, August 3rd. Weiss Ratings reissued a “hold (c+)” rating on shares of Colgate-Palmolive in a research report on Friday, July 31st. Morgan Stanley restated an “overweight” rating and issued a $104.00 target price on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Finally, Royal Bank Of Canada raised their price target on shares of Colgate-Palmolive from $102.00 to $104.00 and gave the company an “outperform” rating in a report on Monday, August 3rd. Twelve analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $99.00.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $88.80 on Friday. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82. The stock has a market cap of $70.79 billion, a P/E ratio of 35.24, a price-to-earnings-growth ratio of 4.20 and a beta of 0.33. The stock has a 50 day moving average of $91.88 and a 200-day moving average of $89.87.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 31st. The company reported $0.99 EPS for the quarter, beating analysts’ consensus estimates of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The firm had revenue of $5.36 billion for the quarter, compared to the consensus estimate of $5.36 billion. During the same period in the prior year, the firm posted $0.92 EPS. The firm’s revenue was up 4.9% compared to the same quarter last year. On average, analysts expect that Colgate-Palmolive Company will post 3.87 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Monday, July 20th were paid a dividend of $0.53 per share. The ex-dividend date was Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.4%. Colgate-Palmolive’s dividend payout ratio (DPR) is 84.13%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.